Genomic and transcriptional heterogeneity-based precision in personalized treatment for breast cancer
- PMID: 31507233
- DOI: 10.2217/pme-2019-0036
Genomic and transcriptional heterogeneity-based precision in personalized treatment for breast cancer
Keywords: biomarkers; breast cancer; genome; oncotargets; precision oncology; transcriptome.
Similar articles
-
Precision medicine in breast cancer.Chin Clin Oncol. 2018 Jun;7(3):29. doi: 10.21037/cco.2018.06.04. Chin Clin Oncol. 2018. PMID: 30056731 Review.
-
Genetic heterogeneity in breast cancer: the road to personalized medicine?BMC Med. 2013 Jun 18;11:151. doi: 10.1186/1741-7015-11-151. BMC Med. 2013. PMID: 23800221 Free PMC article. Review.
-
Precision Medicine in Breast Cancer.Radiol Technol. 2017 Mar;88(4):401M-421M. Radiol Technol. 2017. PMID: 28298516 Review.
-
Tumour Heterogeneity of Breast Cancer: From Morphology to Personalised Medicine.Pathobiology. 2018;85(1-2):23-34. doi: 10.1159/000477851. Epub 2018 Feb 10. Pathobiology. 2018. PMID: 29428954 Review.
-
Discovering novel valid biomarkers and drugs in patient-centric genomic trials: the new epoch of precision surgical oncology.Drug Discov Today. 2018 Nov;23(11):1848-1872. doi: 10.1016/j.drudis.2018.07.008. Epub 2018 Aug 2. Drug Discov Today. 2018. PMID: 30077778 Review.
Cited by
-
Comprehensive analysis of pyroptotic gene prognostic signatures associated with tumor immune microenvironment and genomic mutation in breast cancer.Front Immunol. 2022 Aug 25;13:933779. doi: 10.3389/fimmu.2022.933779. eCollection 2022. Front Immunol. 2022. PMID: 36090993 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical